Etid klinik pou Atak kè nan Indiana
4 etid pou Atak kè ap chèche patisipan nan sit nan Indiana.
Tèks ofisyèl etid la (Anglè)
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- NANI Research, Fort Wayne
- Nephrology Physician's LLC, Mishawaka
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05485961An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
- Krannert Institute of Cardiology, Indianapolis
Ap rekriteFaz 3
Laj 18 a 100 · Tout sèks · Mizajou Sep 4, 2026 · NCT07517263OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- MediSphere Medical Research Center LLC, Evansville
- Parkview Research Center, Fort Wayne
- Franciscan Health Indianapolis, Indianapolis
- ak 3 plis
Ap rekriteFaz 3
Laj 50 a 105 · Tout sèks · Mizajou Aug 21, 2026 · NCT07136012Focused Orticumab Research for Treating Inflammation in Coronary Arteries
- Abcentra Investigational Site, Richmond
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jan 27, 2026 · NCT06927739Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.